Inhibitory Effect of Guanfacine, a Central α-Adrenoceptor Agonist, on Prolactin Secretion Stimulated by Insulin-Induced Hypoglycemia
- 1 September 1978
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 47 (3) , 671-674
- https://doi.org/10.1210/jcem-47-3-671
Abstract
In six normal male volunteers oral administration of an α-receptor agonist, guanfacine (1 mg/q.i.d. for 4 days), had no effect on PRL release induced by 5 mg metoclopramide iv. The same treatment with quanfacine in six other normal subjects significantly reduced PRL secretion stimulated by insulininduced hypoglycemia (P < 0.05). These results suggest that an adrenergic pathway, hypothalamic or extrahypothalamic, might be involved in the inhibitory control of PRL secretion.Keywords
This publication has 5 references indexed in Scilit:
- New evidence for growth hormone modulation by the α-adrenergic system in manMetabolism, 1977
- Dopamine in Hypophysial Portal Plasma of the Rat During the Estrous Cycle and Throughout Pregnancy1Endocrinology, 1977
- EFFECT OF METOCLOPRAMIDE ON SERUM PROLACTIN LEVELS IN HUMANSClinical Endocrinology, 1976
- Prolactin Secretion by Metoclopramide in ManJournal of Clinical Endocrinology & Metabolism, 1976
- Metoclopramide Stimulates Prolactin Secretion in ManJournal of Clinical Endocrinology & Metabolism, 1976